Evidence map›Paper›PMID 40570046›Full record

ArticlePLoS neglected tropical diseases2025

A cross-sectional investigation of the ophthalmological impact of loiasis in Cameroon, Central Africa.

Joseph Kamgno, Joseph Kamtchum-Tatuene, Linda Esso, Serge Bertrand Eyebe-Eyebe, Giles Kagmeni, Jean Bopda, Jean Tenaguem, Amy Klion, Hugues Nana-Djeunga, Lucienne Bella-Assumpta and 1 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joseph KamgnoHigher Institute for Scientific and Medical Research (ISM), Yaounde, Cameroun.
Joseph Kamtchum-TatueneHigher Institute for Scientific and Medical Research (ISM), Yaounde, Cameroun.ORCID 0000-0002-1041-4202
Linda EssoDepartment of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
Serge Bertrand Eyebe-EyebeDepartment of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
Giles KagmeniOphthalmology Unit, Yaounde University Teaching Hospital, Yaounde, Cameroon.
Jean BopdaHigher Institute for Scientific and Medical Research (ISM), Yaounde, Cameroun.
Jean TenaguemHigher Institute for Scientific and Medical Research (ISM), Yaounde, Cameroun.
Amy KlionLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
Hugues Nana-DjeungaHigher Institute for Scientific and Medical Research (ISM), Yaounde, Cameroun.
Lucienne Bella-AssumptaDepartment of Surgery and Surgical Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon.
Adrian HopkinsConsultant, Blinding and Neglected Diseases of Poverty, Gravesend, United Kingdom.

Funding

Mectizan Donation ProgramNational Institute of Allergy and Infectious Diseases, National Institutes of Health INTRAMURAL
6 · The paper itself

Abstract

backgroundCurrent knowledge of ocular manifestations of loiasis is limited to the transient subconjunctival passage of the adult filaria and anecdotal reports of posterior segment lesions. Therefore, the ocular burden of loiasis is likely underestimated since it has never been systematically assessed at the population level. We aimed to evaluate the relationship of Loa loa microfilaremia and recent eye worm passage with chronic ocular lesions identified through comprehensive ophthalmological assessment in an endemic area. METHODOLOGY/PRINCIPAL

findingsSubjects aged ≥ 15 years, residing in Akonolinga for ≥ 5 years, without filaricidal treatment for ≥3 years, were screened for filariases. After excluding participants with onchocerciasis lesions, a subset of randomly selected participants was assessed by ophthalmologists blinded to blood test results then allocated to four groups defined by microfilarial load (MFL) on calibrated thick blood film: G1 (Loa MFL = 0), G2 (MFL < 8000/mL), G3 (MFL ≥ 8000/mL), G4 (co-infestation with Mansonella MFL > 100/mL). The ophthalmological assessment comprised distance visual acuity, examination of the anterior segment with a slit lamp, and fundoscopy. The primary analysis consisted of univariable comparisons of the frequency of abnormal findings across four groups (G1 - 4) or two groups defined by history of eye worm passage. The secondary analysis consisted of a multivariable logistic regression analysis of the relationship of high Loa MFL (≥8000/mL) with chorioretinitis and eye worm passage with unilateral ametropia, adjusting for confounders. Of 1511 subjects screened, 200 underwent ophthalmological assessment, including 65, 69, 35, and 16 in G1 to 4. History of eye worm passage in the previous year was reported by 121 participants (65.4%). Unilateral ametropia was more prevalent in people with history of eye worm passage in the previous year (26.5% versus 10.9%, p = 0.014). Chorioretinitis was the most frequent posterior segment lesion (n = 11, 6.1%) and was most prevalent in G3 (14.3%). The frequency of chorioretinitis was higher in participants with moderate-to-severe visual impairment (27.3% versus 4.4%, p = 0.002). High Loa MFL was an independent predictor of chorioretinitis (adjusted OR=5.28; p = 0.01). History of eye worm passage in the previous year was independently associated with unilateral ametropia (adjusted OR=3.27, p = 0.0088). CONCLUSIONS/SIGNIFICANCE: This study has, for the first time, provided evidence of independent association between history of eye worm passage and unilateral ametropia, and between high Loa MFL and severe chorioretinal lesions. This suggests that loiasis should be classified as a neglected tropical disease.

Indexed as

Eye Infections, ParasiticLoiasisAdolescentAdultAgedAnimalsCameroonCross-Sectional StudiesFemaleHumansLoaMaleMiddle AgedPrevalenceYoung Adult

Identifiers

PMID40570046
PMCPMC12225979

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.